...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Trading
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Canadian Securities Administration:

https://cto-iov.csa-acvm.ca/SearchArticles.asp?Instance=101&Form=1&Names1=Zenith+Capital+Corp.%0D%0A&XSL=SearchArticlesCompany

Issued Date Issuing Jurisdiction(s) Status Expiry Date Exception Type

Active Cease Trade Orders
2022/09/07 AB-ON Issued None No Ban Securities Trading OF

 

 

Koo

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply